Radiopharmaceutical practices are divided into large-scale industrial manufacturing and small-scale "in-house" hospital radiopharmacy unit. The recent evolution of nuclear medicine involves deep consequences in this ever-present regulatory state, and hospital radiopharmacy units cannot be considered as contract manufacturing organizations (CMO). This review provides an updated status report of the official (and non-official) guidelines supporting the regulations required to meet hospital and industry common radiopharmaceutical manufacturing standards to facilitate the current and future innovative radiopharmaceutical development.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440975 | PMC |
| http://dx.doi.org/10.3389/fnume.2022.990330 | DOI Listing |
Publication Analysis
Top Keywords
hospital industry
8
hospital radiopharmacy
8
radiopharmaceutical
4
radiopharmaceutical good
4
good practices
4
practices regulation
4
hospital
4
regulation hospital
4
industry radiopharmaceutical
4
radiopharmaceutical practices
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!